Nang Kuang Pharmaceutical Co., Ltd. (1752)
Market Closed
12 Aug, 05:30
TWSE TWSE Primary NT$
32. 10
0
0%
NT$
- Market Cap
- P/E Ratio
0.12% Div Yield
43,127 Volume
- Eps
NT$ 32.1
Previous Close Want to track 1752 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | 0.8 | 0.41 |
| | | 0.65 | 0.49 |
| | | - | - |
| | | 0.59 | 0.54 |
| | | 0.63 | 0.62 |
| | | 0.45 | 0.44 |
| | | 0.33 | 0.44 |
1752 Earnings Reports FAQ
What is the earnings per share (EPS) for 1752?
EPS data for 1752 is currently not available, as Nang Kuang Pharmaceutical Co., Ltd has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 11 years, the earnings growth rate has been approximately -6.82%, reflecting the 1752's performance and TWSE market conditions.
When is the next earnings release date?
Nang Kuang Pharmaceutical Co., Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Nang Kuang Pharmaceutical Co., Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 1752 at this time, as Nang Kuang Pharmaceutical Co., Ltd has no recent EPS data to calculate it.
